
Ackerman and Bunick review 52-week AMETHYST data for litifilimab in refractory cutaneous lupus and make the case for dermatology-led CLE care.
In this video, the second in a 6-part series, panelists discuss recent advancements in PsO management.
In this HCPLive RX Review Special Report, Mona Shahriari, MD, Associate Clinical Professor of Dermatology at Yale University, sits down with David Hartigan, a biologic coordinator with Biologic Coordinators of Dermatology, to dive into the clinical limitations of traditional topical therapies and explore how foam formulations offer meaningful advantages for high-impact areas like the scalp.






